v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Condensed Consolidated Statements of Operations and Comprehensive Loss    
Revenue $ 30  
Cost of revenue 23  
Gross profit 7  
Other operating income 284 $ 433
Operating Expenses:    
Research and development 1,459 4,013
Selling, general and administrative 1,240 3,983
Transaction expenses   1,314
Total operating expenses 2,699 9,310
Loss from operations (2,408) (8,877)
Non-operating (Expense)/Income    
(Loss) on foreign currency transactions (354) (470)
Interest expense   (19)
Total non-operating (expense) (354) (489)
Loss before income taxes (2,762) (9,366)
Net loss (2,762) (9,366)
Other comprehensive loss:    
Foreign currency translation 156 16
Total comprehensive loss $ (2,606) $ (9,350)
Basic net loss per common share $ (0.10) $ (0.51)
Dilutive net loss per common share $ (0.10) $ (0.51)
Basic weighted average shares outstanding 28,438,003 18,351,532
Dilutive weighted average shares outstanding 28,438,003 18,351,532

Source